Skip to content
Head to head

DexCom vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: DXCM · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

DXCM +35.6%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
DXCMABT
Snapshot
SectorMedical DevicesMedical Devices
Last price79.32103.00
Change today-1.08%-0.84%
1-year return+35.8%-15.4%
Market cap$29.58B$178.39B
52-week range56.72 – 92.5980.89 – 126.70
Valuation
P/E (TTM)31.2338.29
P/E percentile, own 5-yr range6th99th
P/B11.673.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)2.093.72
Net profit (TTM)$779.47M$6.44B
Revenue (TTM)$5.10B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+11.2%+14.5%
Gross margin63.4%56.9%
Operating margin24.0%13.8%
Net margin19.4%9.7%
Free cash flow (TTM)$1.73B$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership101.7%81.2%
Insider activity (12mo)11 buy / 38 sell36 buy / 12 sell
Short interest (% of float)4.3%1.1%
Analyst consensus93% buy / 7% hold (15)93% buy / 7% hold (15)
Analyst price target$99 (+25%)$122 (+18%)
StockVane view
StockVane Quant RatingC (78)D (22)
Company
Employees11,100115,000
Founded19991900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.